Streetbeat News

Revenues

FWRG

First Watch Restaurant Gr (NASDAQ:FWRG) has received mixed analyst ratings over the past three months, with a recent average 12-month price target of $22.75, up from $21.75. The company has shown strong revenue growth and net margin but lags in ROE and ROA. Analysts from Raymond James and Barclays have raised their price targets, while Stifel has lowered theirs.

Portfolio Pulse from Benzinga Insights

January 25, 2024 | 1:00 pm

VMC

Vulcan Materials (NYSE:VMC) has been analyzed by 5 analysts, showing a range of opinions. The average 12-month price target is $237.6, with a high of $279.00 and a low of $208.00, reflecting a slight decrease from the previous average of $240.00. Analyst actions include rating changes and price target adjustments, with some raising and others maintaining or lowering their targets. Vulcan Materials is a major producer of construction aggregates in the U.S. with significant market presence but faces challenges in profitability and debt management.

Portfolio Pulse from Benzinga Insights

January 25, 2024 | 1:00 pm

UNP

Union Pacific anticipates muted volume growth in FY24 due to the loss of its international intermodal business, decreased demand for coal, and soft economic conditions.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 12:52 pm

NTCT

NetScout Systems, Inc. has updated its FY24 revenue forecast to approximately $840 million, which is at the lower end of its previous guidance range of $840 million to $860 million. This new forecast is slightly below the consensus estimate of $842.92 million.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 12:35 pm

LASE

Laser Photonics Corporation has received an order from Karavan Trailers for its LPC-1500-CTHD laser cleaning system. This order could indicate growing demand for Laser Photonics' Cleantech products and potentially increase the company's revenues.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 12:19 pm

SHW

Sherwin-Williams projects its FY24 sales to increase by a low to mid-single-digit percentage, indicating a positive outlook for the company's revenue growth in the upcoming fiscal year.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 12:07 pm

RHHBY

RPTX

Repare Therapeutics has received a $40M milestone payment from Roche following the dosing of the first patient in Roche's TAPISTRY Phase 2 trial under their worldwide license and collaboration agreement for the drug Camonsertib.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 12:05 pm

JD

JD.com (NASDAQ:JD) has been analyzed by 6 analysts, showing a mix of bullish and neutral stances. The average 12-month price target is $43.0, up from $42.60, with a high of $67.00 and a low of $30.00. Analysts from Citigroup, Mizuho, Susquehanna, Benchmark, UBS, and Barclays have adjusted their price targets and ratings, reflecting changes in market dynamics and company performance. JD.com's financials show a solid revenue growth rate of 1.71% as of September 30, 2023, but it lags in net margin and ROE while excelling in ROA and debt management.

Portfolio Pulse from Benzinga Insights

January 25, 2024 | 12:00 pm

APTV

Analysts have recently adjusted their ratings and price targets for Aptiv (NYSE:APTV), with six analysts offering opinions ranging from bullish to bearish. Over the past three months, there has been a shift towards a more cautious stance, with the current average 12-month price target at $101.00, down from the previous $115.00. Analysts from firms including JP Morgan, Baird, Morgan Stanley, Barclays, RBC Capital, and Piper Sandler have all lowered their price targets. Aptiv's financial performance shows strong market recognition, revenue growth, profitability, and effective asset utilization, with a market capitalization that surpasses industry averages and a notable net margin of 31.85%.

Portfolio Pulse from Benzinga Insights

January 25, 2024 | 12:00 pm

LEA

Lear Corporation (NYSE:LEA) has received mixed analyst ratings over the past three months, with 2 bullish and 3 somewhat bullish ratings. The average 12-month price target is $182.4, a slight decrease from the previous $183.75. Analysts from firms like JP Morgan and Barclays have adjusted their price targets and ratings, reflecting their latest views on the company's performance. Lear's financials show a positive revenue trend with a growth rate of 10.3% as of September 30, 2023, but below-average net margin, ROE, and ROA. The company has a prudent debt management strategy with a debt-to-equity ratio of 0.57.

Portfolio Pulse from Benzinga Insights

January 25, 2024 | 12:00 pm